CROCE, Carlo Maria
 Distribuzione geografica
Continente #
NA - Nord America 17.004
EU - Europa 3.365
AS - Asia 2.126
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 6
AF - Africa 2
OC - Oceania 2
Totale 22.514
Nazione #
US - Stati Uniti d'America 16.995
CN - Cina 1.365
UA - Ucraina 1.003
TR - Turchia 600
DE - Germania 525
IT - Italia 446
GB - Regno Unito 413
PL - Polonia 344
SE - Svezia 251
FI - Finlandia 223
VN - Vietnam 96
FR - Francia 69
BE - Belgio 25
RU - Federazione Russa 23
IR - Iran 17
NL - Olanda 15
KR - Corea 13
HK - Hong Kong 10
IN - India 9
CA - Canada 7
AT - Austria 6
BR - Brasile 6
GR - Grecia 5
JP - Giappone 5
EU - Europa 4
RO - Romania 4
SG - Singapore 4
MY - Malesia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AU - Australia 2
BG - Bulgaria 2
CH - Svizzera 2
ES - Italia 2
IE - Irlanda 2
RS - Serbia 2
AM - Armenia 1
CL - Cile 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
FK - Isole Falkland (Malvinas) 1
ID - Indonesia 1
IM - Isola di Man 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
NP - Nepal 1
PA - Panama 1
PE - Perù 1
UZ - Uzbekistan 1
Totale 22.514
Città #
Fairfield 2.720
Woodbridge 2.491
Houston 1.590
Ashburn 1.245
Jacksonville 1.154
Seattle 1.068
Chandler 1.001
Ann Arbor 918
Wilmington 892
Cambridge 871
Izmir 419
Warsaw 340
Nanjing 339
Princeton 254
San Diego 233
Beijing 213
Boardman 188
Ferrara 136
Addison 124
Milan 108
Dong Ket 96
Nanchang 94
Shenyang 92
New York 81
Shanghai 78
Dearborn 76
Hebei 70
Mountain View 60
Tianjin 60
Jinan 57
Bremen 56
Jiaxing 52
Changsha 40
Falls Church 40
Kunming 40
Redwood City 39
Norwalk 35
San Mateo 35
Los Angeles 32
Hangzhou 31
Zhengzhou 31
London 30
Tappahannock 28
Orange 27
Des Moines 26
Guangzhou 25
Ningbo 25
Auburn Hills 23
Brussels 23
Verona 23
Taizhou 21
Washington 21
Hefei 19
Philadelphia 18
Indiana 14
Chicago 13
Lanzhou 13
Changchun 12
Augusta 11
Hong Kong 10
Hounslow 9
Redmond 9
Kilburn 7
Monmouth Junction 7
Leawood 6
Vienna 6
Amsterdam 5
Ardabil 5
Berkeley 5
Napoli 5
Tallahassee 5
Bologna 4
Cagliari 4
Casalecchio Di Reno 4
Guiyang 4
Haikou 4
Helsinki 4
Palermo 4
Prescot 4
Singapore 4
Thessaloníki 4
Walnut 4
Wenzhou 4
Acton 3
Capo D'orlando 3
Chiswick 3
Columbus 3
Crevalcore 3
Edinburgh 3
Leeds 3
Rome 3
San Francisco 3
Stockholm 3
Taiyuan 3
Tokyo 3
Atlanta 2
Baotou 2
Belgrade 2
Brescia 2
Catania 2
Totale 18.044
Nome #
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 221
Anti-leukemic activity of microRNA-26a in a chronic lymphocytic leukemia mouse model 165
Loss of miR-204 expression is a key event in melanoma 157
MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia 155
miRNA signatures associate with pathogenesis and progression of osteosarcoma. 153
miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia 152
Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma 150
Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. 148
In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. 148
miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells 147
Identification of microRNA activity by Targets' Reverse EXpression. 145
p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. 144
PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells 143
13q14 deletions in chronic lymphoproliferative disorders with the t(11;14)(q13;q32): a cytogenetic and interphase cytogenetic study. 142
miR-21 and miR-155 are associated with mitotic activity and lesion depth of borderline melanocytic lesions. 141
Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer 140
null 139
MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma 139
Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. 138
The different epidemiologic subtypes of Burkitt lymphoma share a homogenous micro RNA profile distinct from diffuse large B-cell lymphoma. 138
A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis 137
The downregulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. 137
MicroRNA e cancro 136
Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model 136
null 132
MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells 131
MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1 131
13q14 deletion in non-Hodgkin's lymphoma: Correlation with clinicopathologic features 131
Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. 130
null 128
null 128
null 127
MicroRNA expression profiling in human Barrett's carcinogenesis. 127
Knockout mice reveal a tumor suppressor function for Testin 126
Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. 125
MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC 125
MicroRNA involvement in hepatocellular carcinoma 124
MicroRNA genes are frequently located near mouse cancer susceptibility loci 123
Transcriptional map of 170-kb region at chromosome 11p15.5: Identification and mutational analysis of the BWR1A gene reveals the presence of mutations in tumor samples 123
null 122
Tumor suppressor functions of ARLTS1 in lung cancers 121
Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer 121
MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin 121
MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis 121
A novel t(9;11)(p22;q23) with ALL-1 gene rearrangement associated with progression of a myeloproliferative disorder to acute myeloid leukemia 120
An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues 120
null 119
Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. 119
Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors 119
B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice 118
Chromosome aberrations in atypical chronic lymphocytic leukemia: a cytogenetic and interphase cytogenetic study 117
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2 117
Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway. 117
Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF- α stimulation and their possible roles in regulating the response to endotoxin shock 117
Ectopic expression of PLC-β2 in non-invasive breast tumor cells plays a protective role against malignant progression and is correlated with the deregulation of miR-146a 117
null 116
WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function 115
microRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 114
Anti-miR-135b in colon cancer treatment: Results from a preclinical study. 114
A microRNA DNA methylation signature for human cancer metastasis 113
Extensive modulation of a set of microRNAs in primary glioblastoma 112
null 111
MiR-145 participates with TP53 in a death promoting regulatory loop and targets estrogen receptor in human breast cancer cells 111
null 111
mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer 110
MicroRNA deregulation in human thyroid papillary carcinomas 110
Significance of Aberrant Expression of MicroRNAs in Cancer Cells 109
Reprogramming of miRNA networks in cancer and leukemia 109
MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. 108
TCL1 transgenic mouse model as a tool for the study of therapeutic targets and microenvironment in human B-cell chronic lymphocytic leukemia 108
ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias 107
MicroRNAs 221 and 222 bypass quiescence and compromise cell survival 107
Gain of imprinting at chromosome 11p15: a pathogenetic mechanism identified in human hepatocarcinomas 107
Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD 107
The role of microRNA genes in papillary thyroid carcinoma 107
Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development 107
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer 107
A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention 106
Functional Implications of MicroRNAs in Acute Myeloid Leukemia by Integrating MicroRNA and Messenger RNA Expression Profiling 106
A set of NF-κB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer 106
Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia 106
null 105
Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers 105
Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. 104
null 104
Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML 104
Oncogenic role of miR-483-3p at the IGF2/483 locus 104
null 103
Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL 102
MicroRNA-135b promotes cancer progression acting as a downstream effector of oncogenic pathways in colon cancer 102
Mammalian microRNAs: a small world for fine-tuning gene expression 102
A microRNA signature of hypoxia 102
null 101
null 101
microRNA involvement in hepatocellular carcinoma 101
WWOX and p53 dysregulation synergize to drive the development of osteosarcoma 101
MicroRNA-221 targets Bmf in hepatocellular carcinoma and correlates with tumor multifocality 101
Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. 101
Onconase mediated NFKβ downregulation in malignant pleural mesothelioma 101
Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance 100
Totale 12.156
Categoria #
all - tutte 76.232
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 626
Totale 76.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20192.338 0 0 0 0 0 0 0 0 0 0 917 1.421
2019/20205.999 840 224 269 921 460 714 553 619 533 527 198 141
2020/20213.570 279 372 192 417 212 343 159 393 99 413 409 282
2021/20222.760 125 322 264 68 96 110 153 136 82 203 291 910
2022/20232.454 253 100 62 309 385 394 104 260 328 19 134 106
2023/2024806 126 176 60 38 79 182 32 69 24 18 2 0
Totale 22.834